Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/ofid/ofaa130 http://scihub22266oqcxt.onion/10.1093/ofid/ofaa130 32363212!7184359!32363212     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Open+Forum+Infect+Dis 2020 ; 7 (4): ofaa130 Nephropedia Template TP {{tp|p=32363212|t=2020. Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19) |pdf=|usr=}}{{32363212}} gab.com Text Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19) JO: Open Forum Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32363212 #FOAvip Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly emerging viral infection causing coronavirus disease 2019 (COVID-19). Hydroxychloroquine and chloroquine have garnered unprecedented attention as potential therapeutic agents against COVID-19 following several small clinical trials, uncontrolled case series, and public figure endorsements. While there is a growing body of scientific data, there is also concern for harm, particularly QTc prolongation and cardiac arrhythmias. Here, we perform a rapid narrative review and discuss the strengths and limitations of existing in vitro and clinical studies. We call for additional randomized controlled trial evidence prior to the widespread incorporation of hydroxychloroquine and chloroquine into national and international treatment guidelines. Twit Text FOAVip Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19) ????Open Forum Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32363212 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32363212 #FOAvip English Wikipedia <ref>{{Cite pmid|32363212}}</ref> Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19) #MMPMID32363212 Pastick KA; Okafor EC; Wang F; Lofgren SM; Skipper CP; Nicol MR; Pullen MF; Rajasingham R; McDonald EG; Lee TC; Schwartz IS; Kelly LE; Lother SA; Mitja O; Letang E; Abassi M; Boulware DR Open Forum Infect Dis 2020[Apr]; 7 (4): ofaa130 PMID32363212show ga Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly emerging viral infection causing coronavirus disease 2019 (COVID-19). Hydroxychloroquine and chloroquine have garnered unprecedented attention as potential therapeutic agents against COVID-19 following several small clinical trials, uncontrolled case series, and public figure endorsements. While there is a growing body of scientific data, there is also concern for harm, particularly QTc prolongation and cardiac arrhythmias. Here, we perform a rapid narrative review and discuss the strengths and limitations of existing in vitro and clinical studies. We call for additional randomized controlled trial evidence prior to the widespread incorporation of hydroxychloroquine and chloroquine into national and international treatment guidelines. äReview: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2(epmc).pdf DeepDyve Pubget Overpricing